Improved diagnosis of visceral leishmaniasis in humans and cutaneous leishmaniasis in dogs

To date, the diagnosis of the severe infectious disease leishmaniosis is still highly unreliable in endemic areas of Eastern Africa, since the pathogen occurring in these regions differs from pathogens present in other endemic areas of South Africa and Asia. Moreover, leishmaniasis is also spreading in southern Europe because infected dogs represent a major source of risk for the transmission to humans.

A cost-effective and time-efficient diagnostics was developed which provides a more
reliable diagnosis of leishmaniasis in humans and animals as compared to currently
available diagnostics. This diagnostics is particularly suitable for a use as rapid test,
allowing an uncomplicated application outside of clinics and laboratories and
consequently a more efficient and improved diagnosis of leishmaniasis in hospitals
and in the field.

Further information: PDF

TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12

Contact
Dr. Peter Stumpf

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Simplified diagnosis of rare eye diseases

Uveitis experts provide an overview of an underestimated imaging technique. Uveitis is a rare inflammatory eye disease. Posterior and panuveitis in particular are associated with a poor prognosis and a…

Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma

New study identifies NECTIN4 amplification as a promising biomarker – Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn…

A novel universal light-based technique

…to control valley polarization in bulk materials. An international team of researchers reports in Nature a new method that achieves valley polarization in centrosymmetric bulk materials in a non-material-specific way…

Partners & Sponsors